OBJECTIVE: Pregnant women were identified at greater risk and given priority for 2009 H1N1 vaccination during the 2009 through 2010 H1N1 pandemic. We identified factors associated with acceptance or refusal of 2009 H1N1 vaccination during pregnancy. STUDY DESIGN: We conducted an in-person survey of postpartum women on the labor and delivery service from June 17 through Aug. 13, 2010, at 4 New York hospitals. RESULTS: Of 1325 survey respondents, 34.2% received 2009 H1N1 vaccination during pregnancy. A provider recommendation was most strongly associated with vaccine acceptance (odds ratio [OR], 19.4; 95% confidence interval [CI], 12.7-31.1). Also more likely to take vaccine were women indicating the vaccine was safe for the fetus (OR, 12.4; 95% CI, 8.3-19.0) and those who previously took seasonal flu vaccination (OR, 7.9; 95% CI, 5.8-10.7). Race, education, income, and age were less important in accepting vaccine. CONCLUSION: Greater emphasis on vaccine safety and provider recommendation is needed to increase the number of women vaccinated during pregnancy.
OBJECTIVE: Pregnant women were identified at greater risk and given priority for 2009 H1N1 vaccination during the 2009 through 2010 H1N1 pandemic. We identified factors associated with acceptance or refusal of 2009 H1N1 vaccination during pregnancy. STUDY DESIGN: We conducted an in-person survey of postpartum women on the labor and delivery service from June 17 through Aug. 13, 2010, at 4 New York hospitals. RESULTS: Of 1325 survey respondents, 34.2% received 2009 H1N1 vaccination during pregnancy. A provider recommendation was most strongly associated with vaccine acceptance (odds ratio [OR], 19.4; 95% confidence interval [CI], 12.7-31.1). Also more likely to take vaccine were women indicating the vaccine was safe for the fetus (OR, 12.4; 95% CI, 8.3-19.0) and those who previously took seasonal flu vaccination (OR, 7.9; 95% CI, 5.8-10.7). Race, education, income, and age were less important in accepting vaccine. CONCLUSION: Greater emphasis on vaccine safety and provider recommendation is needed to increase the number of women vaccinated during pregnancy.
Authors: Amanda F Dempsey; Sarah E Brewer; Carter Sevick; Jennifer Pyrzanowski; Sara Mazzoni; Sean T O'Leary Journal: Hum Vaccin Immunother Date: 2015-10-02 Impact factor: 3.452
Authors: Kenneth Goodman; Sherif B Mossad; Glen B Taksler; Jonathan Emery; Sarah Schramm; Michael B Rothberg Journal: J Reprod Med Date: 2015 Nov-Dec Impact factor: 0.142
Authors: F Chavant; I Ingrand; A P Jonville-Bera; C Plazanet; V Gras-Champel; L Lagarce; M Zenut; A Disson-Dautriche; S Logerot; M Auffret; A Coubret-Dumas; M L Bruel; M Boyer; M A Bos-Thompson; G Veyrac; P Carlier; M N Beyens; S Lates; C Damase-Michel; A Castot; C Kreft-Jaïs; M C Pérault-Pochat Journal: Drug Saf Date: 2013-06 Impact factor: 5.606
Authors: Daina A Blitz; Jonathan R Mallen; Thomas G Kwiatkowski; Jill M Rabin; Yosef D Dlugacz; Robert A Silverman Journal: Adv Med Educ Pract Date: 2015-04-15